Cèl·lules mare embrionàries: què en sabem després de trenta anys d'investigació?

Authors

  • Núria Montserrat i Pulido
  • Begoña Aran Corbella
  • Juan Carlos Izpisúa Belmonte

Abstract

Human embryonic stem cells: What do we known after thirty years of research? The isolation and derivation of human embryonic stem cells (hESCs) in 1998 attracted significant attention in the regenerative medicine field. Among other properties, these cells possessed the dual ability to self-renew and differentiate into all the cell types of the body. These characteristics suggest that hESCs hold great potential for application in regenerative medicine. However, after more than twenty years of intense research, their clinical application still shows many concerns regarding the use of human embryos, tissue rejection after transplantation, and tumour formation. Thus, one of the ultimate goals in regenerative medicine is the generation of pluripotent hESCs directly from somatic cells obtained from patients. A breakthrough appeared when fully differentiated cells were reprogrammed for the first time in 2006 into ES-like cells. The resulting ES-like cells exerts all the characteristics intrinsic to ESC biology and finally could overcome the issue related with immune rejection after transplantation and the use of human embryos for research. Nevertheless, most of the techniques used to reprogram human somatic cells are still not adaptable for immediate clinical applications. Improvements in their safe derivation and validation will bring them one step closer for becoming the ideal alternative in cell-replacement therapies and disease modelling in vitro.

Published

2012-03-01